Here are relevant reports on : nuclear-energy-market
-
Nuclear Medicine Software Market by Software (Image Management, Workflow, PACS, Dosimetry, Treatment, AI/Analytics), Application (Diagnosis, Treatment, Theranostics, Research), Disease (Onco, Neuro, Cardio), End User & Region - Global Forecast to 2030
The global nuclear medicine software market, valued at US$887.5million in 2024, stood at US$970.0 million in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of US$1,491.5 million by the end of the period. This growth is mainly driven by the increasing demand for early and accurate diagnostics, as precision imaging is essential for treatment planning.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Nuclear Power Plant Control System Market by Component (Hardware, Software, Services), Solution (SCADA, PLC, DCS), Application (Generator Excitation & Electrical Control, Turbine & Auxiliaries Control System) and Region - Global Forecast to 2028
The global nuclear power plant control system market is projected to reach USD 825 million by 2028, at a CAGR of 5.3% during the forecast period. Some of the major players in the nuclear power plant control system market are Siemens (Germany), ABB (Switzerland), General Electric (US), Fortum (Finland), and Framatome (France). The major strategies adopted by these players include new product launches, acquisitions, contracts, agreements, partnerships, joint ventures, collaborations, investments, and expansions.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Inorganic Mass Spectrometry Market by Product (Inductively Coupled Plasma-Mass Spectrometry, Isotope Ratio Mass Spectrometry) & Application (Nuclear Science, Metrology, and Industrial Chemistry) - Analysis & Global Forecast to 2020
Inorganic Mass spectrometry is an analytical technique used for multi elemental determination of elements at the trace and ultratrace level in high-purity materials. The mass spectrometry market is segmented on the basis of product and application. The mass spectrometry market, by product, is segmented into isotope ratio mass spectrometry (IRMS), multi-collector mass spectrometry (MC/IRMS), inductively coupled plasma mass spectrometry (ICP/MS), and high resolution trace mass spectrometry (HR Trace/MS)
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Construction Robot Market by Type (Traditional, Robotic Arm, and Exoskeleton), Automation, Function, Application (Public Infrastructure, Commercial and Residential Buildings, Nuclear Dismantling and Demolition), and Geography - Global Forecast to 2035
The construction robot market is expected to reach USD 166.4 Million by 2023 from USD 76.6 Million in 2018, at a CAGR of 16.8%. The construction robot market is mainly driven by factors such as enhanced productivity, quality, and safety due to the implementation of construction robots and growing urbanization worldwide. The report profiles the most promising players in the market. The competitive landscape of the market is highly dynamic because of the presence of a significant number of big and small players operating in it. Key players in the market are Brokk (Sweden), Husqvarna (Sweden), Ekso Bionics (US), Komatsu (Japan), Fujita (Japan), Construction Robotics (US), Fastbrick Robotics (Australia), Autonomous Solutions (US), Conjet (Sweden), TopTec Spezialmaschinen (Germany), Apis Cor (Russia), nLink (Norway), Yingchuang Building Technique Co. (WinSun) (China), Advanced Construction Robotics (US), MX3D (Netherlands), CyBe Construction (Netherlands), CYBERDYNE (Japan), Giant Hydraulic Tech (China), Alpine Sales and Rental (US), and Beijing Borui Intelligent Control Technology (China).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Preclinical Imaging Market by Product (Optical Imaging (Bioluminescence), Nuclear Imaging (PET, SPECT), MRI, Reagents (Luciferins, Infrared Dyes), Software), Application (Onco, Cardio), End User (Pharma, Biotech, Academic, CRO) - Global Forecast to 2030
The global preclinical imaging market, valued at US$3.36 billion in 2024, stood at US$3.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.5% from 2024 to 2030, culminating in a forecasted valuation of US$4.39 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology, Thyroid, Oncology), Procedures, End User - Global Forecast to 2028
The global nuclear medicine market, valued at US$4.9 billion in 2021, stood at US$5.5 billion in 2023 and is projected to advance at a resilient CAGR of 11.3% from 2023 to 2028, culminating in a forecasted valuation of US$9.4 billion by the end of the period. The market growth in this sector is driven by factors such as advancements in radioisotope production technology and the rising prevalence of cancer and cardiovascular diseases (CVD).
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) & Region - Global Forecast to 2025
The global nuclear imaging equipment market growth is primed to transition from $2.6 billion in 2020 to $3.4 billion by 2025, showcasing a strong CAGR of 7.4%. The growth in this market is mainly driven by the the shift from standalone to hybrid modalities, advances in radiotracers, the increasing focus on personalized medicine, investments through public-private partnerships to modernize diagnostic imaging centers, and the increasing incidence and prevalence of cancer and cardiac ailments.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017
The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012. Radioisotopes in the diagnostic market are categorized as SPECT and PET. Technetium 99m (Tc-99m) dominated the SPECT radioisotope market in 2012, followed by thallium–201(Tl-201), gallium–67 (Ga-67), and iodine-123 (I-123). SPECT is majorly used in cardiology-related diagnosis; it is poised to grow at a CAGR of 10.2% from 2012 to 2017. The radiopharmaceuticals market in the Asia-Pacific region was valued at $500.8 million in 2012; it is poised to reach $824.9million in 2017 at a CAGR of 10.5%.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), Application (Oncology, Thyroid, Cardiology), Procedures - Forecasts to 2020
Over the years, the European nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The European radiopharmaceuticals market is witnessing growth owing to an increasing number of radioisotope approvals for different clinical indications. Tc-99m and F-18 radioisotopes are estimated to contribute the highest to the European nuclear medicine diagnostic market in 2015, whereas Ra-223, I-131 and Y-90 ensured their leading position in the therapeutic market. The European nuclear medicine/radiopharmaceuticals market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, growing at a CAGR of 8.2% from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Nuclear Power Plant Equipment Market by Reactor Type (Pressurized Water Reactor (PWR), Pressurized Heavy Water Reactor (PHWR), Boiling Water Reactor (BWR)), Equipment Type (Island Equipment, Auxiliary Equipment) Region - Global Forecast to 2027
The global Nuclear power plant equipment market is projected to reach USD 18.6 billion by 2027, at a CAGR of 3.5% during the forecast period. The leading players in the Nuclear power plant equipment market such as General Electric (US), Mitsubishi Heavy Industries (Japan), Toshiba Energy System & Solutions Corporation (Japan), Doosan Corporation (South Korea). Westinghouse Electric Company (US), Shanghai Electric (China).
- Published: January 2023
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
